Related topics

Oxford Immunotec: 3Q Earnings Snapshot

November 5, 2019 GMT

ABINGDON, Britain (AP) _ Oxford Immunotec Global PLC (OXFD) on Tuesday reported third-quarter net income of $717,000, after reporting a loss in the same period a year earlier.

On a per-share basis, the Abingdon, Britain-based company said it had profit of 3 cents. Earnings, adjusted to account for discontinued operations, were 4 cents per share.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 5 cents per share.

The immunology diagnostics company posted revenue of $21.2 million in the period, which also beat Street forecasts. Three analysts surveyed by Zacks expected $20.4 million.

For the current quarter ending in December, Oxford Immunotec said it expects revenue in the range of $16.4 million to $17.4 million.

The company expects full-year revenue in the range of $72 million to $73 million.

Oxford Immunotec shares have climbed 26% since the beginning of the year. The stock has risen almost 2% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OXFD at https://www.zacks.com/ap/OXFD